Rise Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-250
| Closed | -$4.51K | – | 1218 |
|
|
2024
Q3 | $4.51K | Sell |
250
-240
| -49% | -$4.33K | ﹤0.01% | 1090 |
|
|
2024
Q2 | $7.97K | Hold |
490
| – | – | ﹤0.01% | 1047 |
|
|
2024
Q1 | $6.92K | Hold |
490
| – | – | ﹤0.01% | 1076 |
|
|
2023
Q4 | $5.12K | Hold |
490
| – | – | ﹤0.01% | 377 |
|
|
2023
Q3 | $5K | Hold |
490
| – | – | ﹤0.01% | 378 |
|
|
2023
Q2 | $3.69K | Sell |
490
-300
| -38% | -$2.26K | ﹤0.01% | 444 |
|
|
2023
Q1 | $6.99K | Hold |
790
| – | – | 0.01% | 411 |
|
|
2022
Q4 | $7.21K | Hold |
790
| – | – | 0.01% | 397 |
|
|
2022
Q3 | $6K | Hold |
790
| – | – | 0.01% | 424 |
|
|
2022
Q2 | $6K | Hold |
790
| – | – | 0.01% | 423 |
|
|
2022
Q1 | $7K | Hold |
790
| – | – | 0.01% | 378 |
|
|
2021
Q4 | $6.33K | Buy |
+790
| New | +$6.33K | 0.01% | 377 |
|